METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN PATIENTS WITH ISOLATED FORM OF ACANTHOLYTIC VESICULAR DISEASE OF ORAL CAVITY Russian patent published in 2019 - IPC G01N33/53 

FIELD: medicine.

SUBSTANCE: method of assessing the clinical effectiveness in the patients with the isolated form of acantholytic pemphigus comprises oral fluid examination, wherein on 14th day of treatment, the concentration of interleukin-4 (IL-4), interleukin-6 (IL-6) and interleukin-1β (IL-1β) and with IL-4 values 46 pg/ml and higher, IL-6 1.5 pg/ml and below, IL-1β 85 pg/ml and lower treatment efficiency is assessed as low, and with IL-4 values 43 pg/ml and lower, IL-6 2.0 pg/ml and higher, IL-1β 89.0 pg/ml and higher clinical effectiveness is considered to be high.

EFFECT: invention refers to dermatology, dentistry and clinical laboratory diagnostics.

1 cl, 2 ex